No connection

Search Results

Corporate Score 42 Bullish

Alamar Biosciences Shares Surge 40% Following Upsized IPO

Apr 17, 2026 17:25 UTC
ALMR
Immediate term

Proteomics firm Alamar Biosciences saw a significant price jump following its public debut. The company raised approximately $191 million through an upsized offering of 11.3 million shares.

  • Shares climbed ~40% on Friday
  • Raised approximately $191 million in gross proceeds
  • Upsized offering totaled 11.3 million shares
  • Opening price recorded at $22.60
  • Company is based in Fremont, California

Alamar Biosciences (ALMR), a commercial-stage proteomics company based in Fremont, California, experienced a strong market reception on Friday, with shares climbing approximately 40% shortly after its initial public offering. The surge followed the company's decision to upsize its IPO, reflecting robust investor demand for its proteomics technology. The firm successfully priced the offering of roughly 11.3 million shares to capitalize on this interest. Financially, the upsized offering allowed Alamar to raise approximately $191 million in gross proceeds. Trading activity began with shares opening at $22.60 around 12:30 pm. The positive price action suggests strong initial confidence in the company's commercial-stage operations and its potential to scale within the specialized proteomics sector.

Sign up free to read the full analysis

Create a free account to unlock full AI-curated market articles, personalized alerts, and more.

Share this article

Related Articles

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Home
Terminal
AI
Markets
Profile